AT332530B - Verfahren zur herstellung von stoffgemischen fur pharmazeutische zwecke - Google Patents

Verfahren zur herstellung von stoffgemischen fur pharmazeutische zwecke

Info

Publication number
AT332530B
AT332530B AT99173*#A AT99173A AT332530B AT 332530 B AT332530 B AT 332530B AT 99173 A AT99173 A AT 99173A AT 332530 B AT332530 B AT 332530B
Authority
AT
Austria
Prior art keywords
mixtures
preparation
pharmaceutical purposes
pharmaceutical
purposes
Prior art date
Application number
AT99173*#A
Other languages
German (de)
English (en)
Other versions
ATA99173A (de
Inventor
Karl Heinrich Pegel
Original Assignee
Liebenberg R W
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liebenberg R W filed Critical Liebenberg R W
Publication of ATA99173A publication Critical patent/ATA99173A/de
Application granted granted Critical
Publication of AT332530B publication Critical patent/AT332530B/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
AT99173*#A 1972-02-03 1973-02-05 Verfahren zur herstellung von stoffgemischen fur pharmazeutische zwecke AT332530B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA720698A ZA72698B (en) 1972-02-03 1972-02-03 Method of preparing medicinal compositions

Publications (2)

Publication Number Publication Date
ATA99173A ATA99173A (de) 1976-01-15
AT332530B true AT332530B (de) 1976-10-11

Family

ID=25564442

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99173*#A AT332530B (de) 1972-02-03 1973-02-05 Verfahren zur herstellung von stoffgemischen fur pharmazeutische zwecke

Country Status (12)

Country Link
AT (1) AT332530B (enrdf_load_stackoverflow)
AU (1) AU468003B2 (enrdf_load_stackoverflow)
BE (1) BE794027A (enrdf_load_stackoverflow)
CA (1) CA1028952A (enrdf_load_stackoverflow)
DE (1) DE2303247A1 (enrdf_load_stackoverflow)
ES (1) ES410733A1 (enrdf_load_stackoverflow)
FR (1) FR2173987B1 (enrdf_load_stackoverflow)
GB (1) GB1365661A (enrdf_load_stackoverflow)
IE (1) IE37464B1 (enrdf_load_stackoverflow)
IL (1) IL41289A (enrdf_load_stackoverflow)
NL (1) NL7301301A (enrdf_load_stackoverflow)
ZA (1) ZA72698B (enrdf_load_stackoverflow)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2659466A1 (de) * 1976-12-30 1979-02-15 Roecar Holdings Nv Steroline und deren verwendung
KR830005852A (ko) * 1980-07-18 1983-09-14 미첼 페터 잭슨 피부와 점막의 비루스 감염치료에 적합한 국소치료제의 제조방법
JPS5874619A (ja) * 1981-10-29 1983-05-06 Nippon Shinyaku Co Ltd リポソ−ム及びその製法
DE3829643A1 (de) * 1988-09-01 1990-03-15 Roecar Holdings Nv Phyto- und zoosterole und deren derivate mit verbesserter wasserloeslichkeit
EP0509656B1 (en) * 1991-03-28 1996-09-18 Rooperol (Na) Nv Compositions of phytosterols and phytosterolins as immunmodulators
SE512958C2 (sv) 1998-04-30 2000-06-12 Triple Crown Ab Kolesterolsänkande komposition innehållande beta-sitosterol och/eller beta-sitostanol samt förfarande för dess framställning
SE517769C2 (sv) 1999-10-29 2002-07-16 Triple Crown Ab Kolesterol och blodfettsänkande komposition, innehållande fytosteroler, blandade med monoglycerider
US7306819B2 (en) 2002-06-12 2007-12-11 The Coca-Cola Company Beverages containing plant sterols
MXPA04012456A (es) 2002-06-12 2005-02-17 Coca Cola Co Bebidas que contienen esteroles vegetales.
MY142989A (en) * 2004-03-10 2011-02-14 Bayer Schering Pharma Ag Stabilised supersaturated solids of lipophilic drugs
EP2238979A1 (en) * 2009-04-06 2010-10-13 LEK Pharmaceuticals d.d. Active pharmaceutical ingredient adsorbed on solid support

Also Published As

Publication number Publication date
CA1028952A (en) 1978-04-04
IL41289A (en) 1975-12-31
BE794027A (fr) 1973-05-02
DE2303247A1 (de) 1973-08-09
IE37464B1 (en) 1977-08-03
FR2173987B1 (enrdf_load_stackoverflow) 1977-10-28
GB1365661A (en) 1974-09-04
IE37464L (en) 1973-08-03
FR2173987A1 (enrdf_load_stackoverflow) 1973-10-12
ZA72698B (en) 1973-09-26
IL41289A0 (en) 1973-03-30
AU468003B2 (en) 1975-12-18
AU5106873A (en) 1974-07-18
ES410733A1 (es) 1976-04-01
ATA99173A (de) 1976-01-15
NL7301301A (enrdf_load_stackoverflow) 1973-08-07

Similar Documents

Publication Publication Date Title
AT332530B (de) Verfahren zur herstellung von stoffgemischen fur pharmazeutische zwecke
AT324524B (de) Verfahren zur herstellung von gerbstoff-formulierungen
AT327190B (de) Verfahren zur herstellung von 1-hydroxi-2-pyridonen
AT319931B (de) Verfahren zur Herstellung von N-(1-Äthyl-α-pyrrolidylmethyl)-2-methoxy-5-sulfamidobenzamid
AT321891B (de) Verfahren zur herstellung von 2-alkoxy-5-alkyl-sulfonylbenzoesäuren
AT330143B (de) Verfahren zur herstellung von 2-substituierten 4-hydroxy -2- cyclopenten -1- onen
AT320627B (de) Verfahren zur Herstellung von α-Deoxytetracyclinen
AT329536B (de) Verfahren zur herstellung von 2-alkoxy-5-alkylsulfonylbenzoesauren
DE2316050A1 (de) Verfahren zur herstellung von 2-hydroxyaethylimino-diacetonitril und 2-hydroxyaethylimino-diacetaten
AT336009B (de) Verfahren zur herstellung von 2-amino-2-oxazolinen
AT326648B (de) Verfahren zur herstellung von 2-nitro-benzofuranderivaten
AT331240B (de) Verfahren zur herstellung von 4-chlor-2-hydroxybenzothiazol
AT321269B (de) Verfahren zur Herstellung von p-Phenylendiamin
AT337163B (de) Verfahren zur herstellung von n-aminoathylbenzamiden
AT321924B (de) Verfahren zur herstellung von 1-hydrazino-phthalazin-hydrochlorid
AT332875B (de) Verfahren zur herstellung von benzodiazepin -2-on- derivaten
AT320657B (de) Verfahren zur Herstellung von 3-Phenyl-6-halogen-pyridazinverbindungen
AT328080B (de) Verfahren zur herstellung von 7-acylamido-7-alkoxycephalosporinverbindungen
AT321890B (de) Verfahren zur herstellung von 2-alkoxy-5-alkylsulfonybenzoesäuren
AT325611B (de) Verfahren zur herstellung von neuen benzopyran-derivaten
AT317123B (de) Verfahren zur Herstellung von 3-Fluor-D-alanin
AT333261B (de) Verfahren zur herstellung von n-aminoalkylbenzamiden
ATA573073A (de) Verfahren zur herstellung von benzocycloheptaoxazolonen
ATA938773A (de) Verfahren zur herstellung von n-aminoalkylbenzamiden
AT329776B (de) Verfahren zur herstellung von benzochinolizin-derivaten

Legal Events

Date Code Title Description
EIH Change in the person of patent owner
ELA Expired due to lapse of time
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties